The detection of minimal residual disease: implications for bone marrow transplantation.
Gribben
J G
JG
Dana-Farber Cancer Institute, Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.
Schultze
J L
JL
D016026:Bone Marrow Transplantation; D015321:Gene Rearrangement; D006801:Humans; D018365:Neoplasm, Residual / Q000175:diagnosis / Q000235:genetics; D016133:Polymerase Chain Reaction